---
$id: https://graph.org.ai/products/commodity/51281679
$type: Product
source: UNSPSC
code: "51281679"
title: "Viomycin hydrochloride"
class: "51281600"
classTitle: "Aminoglycosides"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Viomycin hydrochloride

**UNSPSC Code**: 51281679
**Class**: [Aminoglycosides](Aminoglycosides.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes the hydrochloride form of an antitubercular agent with the molecular structure C25H43N13O10, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, YVU35998K5 chemically known as glycine, 3-amino-n-((3s)-3,6-diamino-1-oxohexyl)-l-alanyl-l-seryl-l-seryl-(2z)-3-((aminocarbonyl)amino)-2,3-didehydroalanyl-2-((4r,6s)-2-amino-1,4,5,6-tetrahydro-6-hydroxy-4-pyrimidinyl)-, (5->13)-lactam, (2s)-, but more commonly known as viomycin, which bears US NIH Compound Identifier 3032902. European Medicines Agency schedules Viomycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00078MIG. The term VIOMYCIN is an International Non-Proprietary Name or INN. Most nations, for tariff and trade purposes, schedule viomycin hydrochloride under HS 29419000. SMILES: C1[C@@H](N=C(N[C@H]1O)N)[C@H]2C(=O)NC[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N/C(=C\NC(=O)N)/C(=O)N2)CO)CO)NC(=O)C[C@H](CCCN)N.CL.CL.CL.

